Erratum: Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study
O
Odile Oberlin
A
Annie Rey
J
José Sanchez de Toledo
H
Hélène Martelli
M
Meriel E.M. Jenney
M
Marcelo Scopinaro
C
Christophe Bergeron
J
Johannes H.M. Merks
(Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands)
N
Nathalie Bouvet
C
Caroline Ellershaw
A
Anna Kelsey
(Department of Pathology, Royal Manchester Children's Hospital, Manchester, United Kingdom)
D
David Spooner
M
Michael C.G. Stevens
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 43, Issue 11
Published
April 10, 2025
Pages
1398-1398
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (13)
O
Odile Oberlin
A
Annie Rey
J
José Sanchez de Toledo
H
Hélène Martelli
M
Meriel E.M. Jenney
M
Marcelo Scopinaro
C
Christophe Bergeron
J
Johannes H.M. Merks
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
N
Nathalie Bouvet
C
Caroline Ellershaw
A
Anna Kelsey
Department of Pathology, Royal Manchester Children's Hospital, Manchester, United Kingdom
D
David Spooner
M
Michael C.G. Stevens
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001